In addition, many TXNRD1-inhibiting drugs can simultaneously activate Nrf2 [33], which helps to protect normal cells from oxidative damage so as to inhibit their induction and transformation associated with cancer [43, 44]. Here, TXNRD1 is linked to cancer.